Penta Real Estate has emerged as a primary catalyst for the investment group’s performance in 2025, spearheading an international expansion that now includes major residential developments in the United Kingdom.
The group’s real estate arm reached a milestone by managing its highest number of simultaneous projects to date, including ten in the Czech Republic, two in Slovakia, and three in London. A pivotal 50:50 joint venture with developer Ballymore is set to deliver over 1,000 new homes in the British capital, with a combined gross development value of £1 billion. By the end of 2025, Penta Real Estate reported total assets exceeding €2.1 billion.
"The recent years have been characterised by a high level of geopolitical challenges, such as wars in Ukraine and now in the Middle East. Despite this, our investment group has managed to achieve above-average economic results during this period," Iain Child, Managing Partner of Penta, said.
The broader Penta Group achieved a record net profit of €714 million in 2025, a significant increase supported by a total CAPEX of €1 billion. While real estate provided significant momentum, the Dr. Max pharmacy chain remained the largest profit contributor, expanding to over 3,200 shops across Europe and completing vertical integration in Serbia.
During 2025, Penta Hospitals International expanded its presence in the Czech Republic and established a market-leading position in Poland's elderly care sector. At the same time, Fortuna Entertainment Group accelerated its digital transition, with online revenues nearing 80%, and reactivated its M&A strategy in Montenegro. Meanwhile, Primabanka and Privatbanka both delivered improved results; the latter placed nearly €500 million in debt securities and €189 million in the newly launched Penta Funds.
